Ahmadi Mahsa, Rasi Hossien, Mostafazadeh Mostafa, Hajazimian Saba, Maroufi Nazila Fathi, Nahaei Mohammad Reza, Rahaee Shiva, Isazadeh Alireza
.
Horm Mol Biol Clin Investig. 2017 Jun 13;31(3):/j/hmbci.2017.31.issue-3/hmbci-2017-0019/hmbci-2017-0019.xml. doi: 10.1515/hmbci-2017-0019.
Objective Cervical cancer (CC) is one of the leading causes of deaths from cancer among women worldwide. Viral infections is now one of the known risk factors for CC. The aim of this study was to investigate the presence of herpes simplex virus type 2 (HSV-2), human papilloma virus types 16 (HPV-16) and human papilloma virus types 18 (HPV-18) in Iranian patients with CC using the polymerase chain reaction (PCR). Materials and methods This case-control study was conducted on a total of 45 patients with CC from Khatam-Al-Anbiya Hospital, Hamadan, Iran during 2014, and 30 samples from healthy subjects as controls. The presence of HSV-2 and HPV-16/18 DNA sequences was detected by PCR. Results Eight of CC patients (17.77%) had HPV-16/18 DNA and only one patient (2.22%) with HSV-2 was identified. These viruses were not detected in control cases. Among HPV-16/18 positive patients, 62.5% and 37.5% biopsies were positive for HPV-16 and HPV-18, respectively. On the other hand, only one case (2.22%) was positive for HPV-16/18, but HSV-2 and this co-infection was not detected in the control group. Conclusion Our results demonstrate that there was no direct molecular evidence to support a cofactor relationship between HSV-2 and HPV-16/18 in cervical malignancies. However, the results about HPV-16/18 was in accordance with previous studies.
目的 宫颈癌(CC)是全球女性癌症死亡的主要原因之一。病毒感染是目前已知的CC危险因素之一。本研究的目的是使用聚合酶链反应(PCR)检测伊朗CC患者中单纯疱疹病毒2型(HSV-2)、人乳头瘤病毒16型(HPV-16)和人乳头瘤病毒18型(HPV-18)的存在情况。
材料与方法 本病例对照研究于2014年对来自伊朗哈马丹Khatam-Al-Anbiya医院的45例CC患者进行,同时选取30例健康受试者的样本作为对照。通过PCR检测HSV-2和HPV-16/18 DNA序列的存在情况。
结果 8例CC患者(17.77%)检测到HPV-16/18 DNA,仅1例患者(2.22%)检测到HSV-2。对照组未检测到这些病毒。在HPV-16/18阳性患者中,分别有62.5%和37.5%的活检样本HPV-16和HPV-18呈阳性。另一方面,仅1例(2.22%)HPV-16/18呈阳性,但对照组未检测到HSV-2及这种合并感染。
结论 我们的结果表明,没有直接的分子证据支持HSV-2与HPV-16/18在宫颈恶性肿瘤中存在辅助因子关系。然而,关于HPV-16/18的结果与先前的研究一致。